Comparing the costs and benefits of the use of an mRNA HR-HPR assay to a DNA HR-HPV assay in the proposed cervical screening programme in France
Cervical cancer is the fourth most common cancer in women aged 15 to 44 years in France. With the implementation of cytology-based cervical screening, cervical cancer incidence and mortality have decreased over time, however, cervical cancer remains a concern. As cervical cancer is primarily caused by persistent infection with high-risk human papillomaviruses (HR-HPV), guidelines for Read More >
Further evidence that point of care (POC) testing for STIs means better clinical care for patients
Most people are now familiar with using rapid diagnostic tests with many people regularly using lateral flow tests for COVID-19. Within sexual health clinics, rapid testing for HIV has been widely used for a number of years but using rapid tests for other sexually transmitted infections (STIs) such as chlamydia and gonorrhoea is not yet Read More >
Research in Dravet syndrome and cervical cancer screening presented at international conferences
Aquarius has recently presented posters at international conferences (ISPOR, a conference for the leading professional society for health economics and outcomes research and EUROGIN, an international multidisciplinary HPV conference), exploring the impact of improving healthcare for two very different conditions: Dravet syndrome (rare debilitating epilepsy) and cervical cancer.
Is it cost effective to screen women for syphilis twice during pregnancy?
The UK National Screening Committee (UK NSC) asked Aquarius to assess the costs and benefits of two different approaches to antenatal screening for syphilis. We compared the current strategy – screening in the first trimester only – with an alternative strategy – screening in the first trimester and a repeat screen later in pregnancy. The Read More >
Could we optimise testing for gonorrhoea to avoid the use of last-line antibiotics?
Ceftriaxone is the first-line treatment for gonorrhoea but there are few alternative treatments available should ceftriaxone resistance become widespread. Aquarius created a model to explore how point-of-care testing could be used to diagnose gonorrhoea and at the same time test for antibiotic susceptibility, which could allow the use of previously abandoned antibiotics for many patients, Read More >
How can economic models inform decision-making about screening programmes?
Dr Elisabeth Adams, Managing Director and Founder of Aquarius Population Health, spoke at a continuing medical education webinar for health professionals hosted on September 23,2020 by the Consortium for Infectious Disease Control (CIDC). With increasing demands on time and resources, decision-makers in healthcare need information about how to create a safe, effective and cost-effective Read More >